The acute airway narrowing that occurs as a result of exercise is defined exercise-induced bronchoconstriction (EIB). Most recent guidelines recommend distinguishing EIB with underlying clinical asthma (EIBA) from the occurrence of bronchial obstruction in subjects without other symptoms and signs of asthma (EIBwA). EIB has been in fact reported in up to 90 % of asthmatic patients, reflecting the level of disease control, but it may develop even in subjects without clinical asthma, particularly in children, athletes, patients with atopy or rhinitis and following respiratory infections. Both EIBA and EIBwA have peculiar pathogenic mechanisms, diagnostic criteria and responses to treatment and prevention. The use of biomarkers, proteomic approaches and innovative technological procedures will hopefully contribute to better define peculiar phenotypes and to clarify the role of EIB as risk factor for the development of asthma, as well as an occupational disease.

Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment / Bonini, Matteo; Palange, Paolo. - In: ASTHMA RESEARCH AND PRACTICE. - ISSN 2054-7064. - 1:1(2015), p. 2. [10.1186/s40733-015-0004-4]

Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment

BONINI, MATTEO;PALANGE, Paolo
2015

Abstract

The acute airway narrowing that occurs as a result of exercise is defined exercise-induced bronchoconstriction (EIB). Most recent guidelines recommend distinguishing EIB with underlying clinical asthma (EIBA) from the occurrence of bronchial obstruction in subjects without other symptoms and signs of asthma (EIBwA). EIB has been in fact reported in up to 90 % of asthmatic patients, reflecting the level of disease control, but it may develop even in subjects without clinical asthma, particularly in children, athletes, patients with atopy or rhinitis and following respiratory infections. Both EIBA and EIBwA have peculiar pathogenic mechanisms, diagnostic criteria and responses to treatment and prevention. The use of biomarkers, proteomic approaches and innovative technological procedures will hopefully contribute to better define peculiar phenotypes and to clarify the role of EIB as risk factor for the development of asthma, as well as an occupational disease.
2015
Asthma; Athlete; Beta-2 agonist; Biomarkers; Bonchoconstriction; Doping; Exercise; Phenotypes; Sport
01 Pubblicazione su rivista::01a Articolo in rivista
Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment / Bonini, Matteo; Palange, Paolo. - In: ASTHMA RESEARCH AND PRACTICE. - ISSN 2054-7064. - 1:1(2015), p. 2. [10.1186/s40733-015-0004-4]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/965290
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact